Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015170 |
---|---|
Receipt number | R000016861 |
Scientific Title | Prospective and randomized controlled study on the efficacy and safety of ipragliflozin and metformin to visceral fat reduction for the patients being treated with DPP-4 inhibitors for poor glycemic controlled type-2 diabetes |
Date of disclosure of the study information | 2014/09/21 |
Last modified on | 2017/05/16 17:10:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/09/16 11:02:39 | ||
2 | Update | 2014/12/10 13:44:58 | Acronym Acronym |
|
3 | Update | 2015/02/09 13:15:02 | Recruitment status |
|
4 | Update | 2015/04/20 15:58:00 | Key exclusion criteria Key exclusion criteria |
|
5 | Update | 2016/03/16 13:33:45 | Last follow-up date |
|
6 | Update | 2016/10/11 14:35:16 | Recruitment status |
|
7 | Update | 2016/10/11 15:27:38 | Key secondary outcomes Key secondary outcomes |
|
8 | Update | 2017/04/25 19:45:42 | Randomization unit |
|
9 | Update | 2017/04/25 19:46:29 | Name of primary person or sponsor Organization |
|
10 | Update | 2017/05/12 20:35:54 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
11 | Update | 2017/05/16 17:10:14 | Recruitment status |